About Raydiant Oximetry
Raydiant Oximetry is a company based in San Ramon (United States) founded in 2015 by Neil Ray. It operates as a HealthTech. Raydiant Oximetry has raised $25.7 million across 14 funding rounds from investors including March of Dimes, HHS and VCI Global. Raydiant Oximetry offers products and services including Lumerah™. Raydiant Oximetry operates in a competitive market with competitors including kegg, Femometer, HeraMED, Noninvasix and OBMedical, among others.
- Headquarter San Ramon, United States
- Founders Neil Ray
-
Sectors
ConsumerHealthcare Technology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Raydiant Oximetry, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$25.7 M (USD)
in 14 rounds
-
Latest Funding Round
$7.5 M (USD), Series A
May 28, 2024
-
Investors
March of Dimes
& 17 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Raydiant Oximetry
Raydiant Oximetry offers a comprehensive portfolio of products and services, including Lumerah™.
Noninvasive fetal pulse oximeter for oxygenation monitoring.
People of Raydiant Oximetry
Unlock access to complete
Unlock access to complete
Funding Insights of Raydiant Oximetry
Raydiant Oximetry has successfully raised a total of $25.7M across 14 strategic funding rounds. The most recent funding activity was a Series A round of $7.5 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Raydiant Oximetry
Raydiant Oximetry has secured backing from 18 investors, including venture fund and institutional investors. Prominent investors backing the company include March of Dimes, HHS and VCI Global.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are focused on health technology for global impact.
|
Locked | Locked | Locked | |
|
Venture capital investment opportunities are provided for accredited investors.
|
Locked | Locked | Locked | |
|
Avestria Ventures is focused on funding women's health and life science ventures.
|
Locked | Locked | Locked |
Investor details for Raydiant Oximetry
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Raydiant Oximetry
Investment portfolio details for Raydiant Oximetry
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Raydiant Oximetry
Detailed financials for Raydiant Oximetry
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Raydiant Oximetry Comparisons
Peer comparison for Raydiant Oximetry
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Raydiant Oximetry
Raydiant Oximetry operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as kegg, Femometer, HeraMED, Noninvasix and OBMedical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Fertility tracking and pelvic health solutions are provided by kegg.
|
|
| Locked | Locked | Locked |
Basal body temperature is tracked by Femometer for cycle monitoring.
|
|
| Locked | Locked | Locked |
Smartphone-based devices for pregnancy monitoring are provided.
|
|
| Locked | Locked | Locked |
Developer of a fetal blood oxygenation monitoring device
|
|
| Locked | Locked | Locked |
Fetal heart rate and contractions are monitored via wireless electrodes.
|
Detailed competitors of Raydiant Oximetry
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Raydiant Oximetry
Complete news archive for Raydiant Oximetry
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Raydiant Oximetry
Raydiant Oximetry was founded in 2015 and raised its 1st funding round 3 years after it was founded.
Raydiant Oximetry is headquartered in San Ramon, United States. It is registered at San Ramon, California, United States.
Neil Ray is the current CEO of Raydiant Oximetry. They have also founded this company.
Raydiant Oximetry is a funded company, having raised a total of $25.7M across 14 funding rounds to date.
Raydiant Oximetry, Inc. is focused on advancing fetal health monitoring during childbirth. The company is developing Lumerah, a noninvasive fetal pulse oximeter designed to measure fetal oxygen levels accurately. This technology aims to reduce maternal and neonatal mortality and morbidity by providing healthcare professionals with reliable data for decision-making during labor and delivery. Operating in the healthcare sector, specifically in medical devices, solutions are targeted at improving outcomes in obstetrics. Partnerships with organizations like GE HealthCare further support the enhancement of fetal monitoring capabilities.
Raydiant Oximetry offers Lumerah™.
Raydiant Oximetry has 18 investors. Key investors include March of Dimes, HHS, VCI Global, AngelMD, and Global Health Impact Network.